Tag: multiple sclerosis

It’s Time for Combination Therapies in Multiple Sclerosis

It’s Time for Combination Therapies in Multiple Sclerosis

| June 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South Carolina. Innov Clin Neurosci. 2017;14(5–6):28–30 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest […]

Continue Reading

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

| April 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40

Continue Reading

Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report

Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report

| February 1, 2017 | 0 Comments

by Michael M. Messer, MD, and Irina V. Haller, PhD, MS Dr. Messer is with Behavioral Health Department, Essentia Health, Duluth, MN, and Dr. Haller is with Essentia Institute of Rural Health, Essentia Health, Duluth, MN, USA. Innov Clin Neurosci. 2017;14(1–2):56–59

Continue Reading

The Potential Role  of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis

The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis

| August 1, 2016 | 0 Comments

by Nazanin Arjomand Fard, MSci; Gholamreza Azizi, PhD; and Abbas Mirshafiey, PhD Dr. Fard is with Kish International Campus, University of Tehran, Tehran, Iran; Dr. Azizi is with Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran and Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran; and […]

Continue Reading

The Neuroscience Report—Vol. 16 (August 17, 2015): Multiple Sclerosis

The Neuroscience Report—Vol. 16 (August 17, 2015): Multiple Sclerosis

| August 17, 2015 | 0 Comments

Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 16 (August 17, 2015): Multiple Sclerosis Journal Articles Electroconvulsive Therapy in […]

Continue Reading

Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors:  New Hope for Success in Multiple Sclerosis Therapy

Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy

| August 16, 2014 | 0 Comments

by Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; and Gholamreza Azizi Dr. Mirshafiey is from the Departmant of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Dr. Ghalamfarsa is from Cellular & Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran; Dr. Asghari is from Antimicrobial Resistance Research Center, Faculty of […]

Continue Reading